ICPerMed “Best Practice in Personalised Medicine” Recognition 2021 – open for applications

10 January 2022

Since 2017 SPHN is full member of the International Consortium for Personalized Medicine (ICPerMed). Recently, ICPerMed launched its fourth Recognition to honour, encourage, promote and disseminate outstanding evidence-based applications in the field of personalised medicine (PM), focusing on the implementation of PM research.

The deadline for proposal submission is extended until 18 February 2022.

The Recognition is open to candidates worldwide, who have published scientific papers (paper accepted by the respective editor) and/or developed best practice strategies (training programmes or interdisciplinary/intersectoral groups of collaboration) for implementation of PM approaches between 1 November 2019 and 31 December 2020. Applications concerning an ongoing or recently accomplished training or collaboration need to be accompanied by a supporting documentation. The submission including the documents to be evaluated (single-stage evaluation) will only be accepted in English and only one submission per applicant is possible.

Those applications addressing outstanding PM outcomes will be announced as winners in 2022 and will be invited to present their approaches during the next ICPerMed Event. The winners will be honoured by a €500 non-cash value support for dissemination.

More information about the recognition: https://www.icpermed.eu/en/887.php

The latest ICPerMed Newsletter was published in December 2021. You can register here for receiving the ICPerMed Newsletter via e-mail.

Scroll to Top